DXM Abuse Prevention Act of 2017

HB 1271 DXM Abuse Prevention Act of 2017

US Congress 115th Congress

DXM Abuse Prevention Act of 2017
HB-1271


About HB-1271

DXM Abuse Prevention Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to:

  • (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer,
  • (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and
  • (3) establish restrictions on the distribution of bulk DXM.

  

Bill Texts

Introduced 03/07/2017

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (7)

Sponsors by party

     

Bill Sponsors

History

Referred To The Subcommittee On Health.

03/17/2017

Introduced In House

03/01/2017

Referred To The House Committee On Energy And Commerce.

03/01/2017